Home › Meningioma › Missouri
Meningioma clinical trials in Missouri
3 studies for Meningioma are looking for participants at sites in Missouri.
Cities in Missouri
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Cox Cancer Center Branson, Branson
- Mercy Cancer Center - Cape Girardeau, Cape Girardeau
- and 18 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Washington University, St Louis
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.